These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28283756)

  • 1. Dopamine, T cells and multiple sclerosis (MS).
    Levite M; Marino F; Cosentino M
    J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases.
    Levite M
    Acta Physiol (Oxf); 2016 Jan; 216(1):42-89. PubMed ID: 25728499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.
    Keren A; Gilhar A; Ullmann Y; Zlotkin-Frušić M; Soroka Y; Domb AJ; Levite M
    Immunology; 2019 Nov; 158(3):171-193. PubMed ID: 31424569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis].
    Melnikov MV; Sviridova AA; Solodova TV; Lopatina AV; Pashenkov MV; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):82-89. PubMed ID: 34387452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Dopaminergic System in Autoimmunity.
    Vidal PM; Pacheco R
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):57-73. PubMed ID: 30661214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.
    Cosentino M; Zaffaroni M; Legnaro M; Bombelli R; Schembri L; Baroncini D; Bianchi A; Clerici R; Guidotti M; Banfi P; Bono G; Marino F
    J Neuroimmunol; 2016 Sep; 298():82-9. PubMed ID: 27609280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of D
    Melnikov M; Sviridova A; Rogovskii V; Kudrin V; Murugin V; Boyko A; Pashenkov M
    Curr Neuropharmacol; 2022; 20(8):1632-1639. PubMed ID: 34429055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.
    Melnikov M; Rogovskii V; Boykо A; Pashenkov M
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):37-47. PubMed ID: 31011885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
    Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
    Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.
    Besser MJ; Ganor Y; Levite M
    J Neuroimmunol; 2005 Dec; 169(1-2):161-71. PubMed ID: 16150496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta.
    Giorelli M; Livrea P; Trojano M
    J Interferon Cytokine Res; 2005 Jul; 25(7):395-406. PubMed ID: 16022584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.
    Nakano K; Yamaoka K; Hanami K; Saito K; Sasaguri Y; Yanagihara N; Tanaka S; Katsuki I; Matsushita S; Tanaka Y
    J Immunol; 2011 Mar; 186(6):3745-52. PubMed ID: 21307293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small GTPase RAS in multiple sclerosis - exploring the role of RAS GTPase in the etiology of multiple sclerosis.
    Messina S
    Small GTPases; 2020 Sep; 11(5):312-319. PubMed ID: 30043672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
    Lieberknecht V; Junqueira SC; Cunha MP; Barbosa TA; de Souza LF; Coelho IS; Santos AR; Rodrigues AL; Dafré AL; Dutra RC
    Mol Neurobiol; 2017 Mar; 54(2):1033-1045. PubMed ID: 26801190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP levels in lymphocytes and CD4
    Cosentino M; Kustrimovic N; Ferrari M; Rasini E; Marino F
    Immunology; 2018 Mar; 153(3):337-341. PubMed ID: 28940477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
    Melnikov M; Pashenkov M; Boyko A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
    Gentile A; Fresegna D; Federici M; Musella A; Rizzo FR; Sepman H; Bullitta S; De Vito F; Haji N; Rossi S; Mercuri NB; Usiello A; Mandolesi G; Centonze D
    Neurobiol Dis; 2015 Feb; 74():347-58. PubMed ID: 25511803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
    Ganor Y; Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.